Mfa Wealth Advisors, LLC Abb Vie Inc. Transaction History

Mfa Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $24,576 - $29,899	-150 Reduced 14.56%	880 $173,000
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $159,433 - $186,182	1,030 New	1,030 $176,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $7.65 Million - $8.68 Million	71,879 New	71,879 $51,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $40,291 - $47,289	-469 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $34,410 - $46,046	469 New	469 $46,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.03 Million - $1.15 Million	-11,592 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $3,501 - $4,142	39 Added 0.34%	11,592 $1.1 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $6,072 - $8,131	66 Added 0.57%	11,553 $1.16 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $1.03 Million - $1.13 Million	11,487	11,487 $1.35 Million

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mfa Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mfa Wealth Advisors, LLC with notifications on news.